SMIM35: A Potential Drug Target and Biomarker (G100526771)

Target Name: SMIM35

NCBI ID: G100526771

SMIM35: A Potential Drug Target and Biomarker

SMIM35 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a scaffold protein that is involved in the structure and function of many different proteins in the body. SMIM35 has been shown to play a role in a variety of biological processes, including the regulation of inflammation, cell signaling, and protein transport. As a result, SMIM35 has potential as a drug target or biomarker.

SMIM35 is a member of the IMP family of proteins, which includes several similar proteins that are involved in the regulation of intracellular signaling. These proteins are characterized by a specific domain that includes a nucleotide-binding oligomerization (NBO) domain, which is responsible for the interaction with DNA and RNA. The NBO domain is responsible for the formation of a DNA-protein complex, which can alter the expression of nearby genes.

SMIM35 is expressed in a variety of tissues and organs, including the brain, heart, and kidneys. It has been shown to be involved in the regulation of inflammation, cell signaling, and protein transport. For example, studies have shown that SMIM35 is involved in the regulation of inflammation in the brain, where it has been shown to play a role in the development of neurodegenerative diseases.

In addition to its potential role in disease, SMIM35 has also been shown to have potential as a drug target. The NBO domain of SMIM35 makes it a potential target for small molecules, which can interact with the protein to alter its function. This has led to the development of several compounds that have been shown to interact with SMIM35 and enhance its activity. These compounds have the potential to be used as drugs for a variety of diseases, including neurodegenerative diseases, cancer, and inflammation.

SMIM35 is also a potential biomarker for a variety of diseases. Its expression has been shown to be altered in a variety of diseases, including neurodegenerative diseases, cancer, and inflammation. These changes in SMIM35 expression can be used as a biomarker to diagnose and monitor the progression of these diseases.

In conclusion, SMIM35 is a protein that has the potential to be a drug target or biomarker. Its involvement in the regulation of inflammation, cell signaling, and protein transport, as well as its potential as a target for small molecules, make it an attractive candidate for drug development. Further research is needed to fully understand the role of SMIM35 in these processes and to develop safe and effective drugs or biomarkers based on it.

Protein Name: Small Integral Membrane Protein 35

More Common Targets